Stay Ahead of the Game With Nutrien (NTR) Q2 Earnings: Wall Street's Insights on Key Metrics

Wall Street analysts project Nutrien (NTR) to report Q2 EPS of $2.40 (+2.6% YoY) and revenues of $10.61 billion (+4.5% YoY). A significant 14.2% upward revision in consensus EPS estimates over the past 30 days is a key highlight, often correlating with positive stock performance. However, while Potash and Nitrogen segments are expected to show growth in sales and volumes, Phosphate sales and volumes are projected to decline alongside lower average selling prices. This mixed outlook, despite the positive estimate revision, aligns with NTR's recent underperformance against the S&P 500 and its current Zacks Rank #3 (Hold).

Analysis

Nutrien (NTR) is approaching its Q2 earnings with a moderately positive analyst consensus, though underlying metrics present a mixed picture. Wall Street forecasts revenue of $10.61 billion and EPS of $2.40, representing year-over-year growth of 4.5% and 2.6%, respectively. The most significant leading indicator is the 14.2% upward revision in the consensus EPS estimate over the last 30 days, a factor empirically linked to positive short-term stock performance. This optimism is driven by expected strength in key segments, with sales projected to grow 4.1% in Retail, 4.9% in Nitrogen, and 6.7% in Potash. Both Nitrogen and Potash are forecast to see increased sales volumes. However, this strength is contrasted by notable weakness in the Phosphate division, where sales are expected to decline by 3.3%, accompanied by lower sales volumes and a drop in the average selling price per tonne from $667 to $651. This segment-specific headwind, combined with the stock's recent underperformance of -1.4% against the S&P 500's +2.3% gain, suggests the market may be weighing the Phosphate weakness against the positive revisions in other areas, aligning with its current Zacks Rank #3 (Hold).

Key Decisions for Investors

• Investors should consider the 14.2% upward revision in consensus EPS as a primary bullish signal, as such significant positive revisions often precede an earnings beat and favorable stock reaction.
• Monitor the Phosphate segment's performance closely, as the projected declines in sales, volumes, and pricing present a key risk that could offset gains in Nitrogen and Potash, potentially capping upside.
• Given the stock's recent underperformance despite positive analyst sentiment, investors should evaluate whether an earnings release that meets or exceeds these heightened expectations could serve as a catalyst for a reversal and close the performance gap with the broader market.